Glycifon ointment for basal cell carcinoma: treatment experience

Рамил Суфиахметович Гараев, Л. Н. Залялютдинова, В. Р. Гильмутдинова, Р. Ш. Хасанов
{"title":"Glycifon ointment for basal cell carcinoma: treatment experience","authors":"Рамил Суфиахметович Гараев, Л. Н. Залялютдинова, В. Р. Гильмутдинова, Р. Ш. Хасанов","doi":"10.17650/2222-1468-2016-6-2-60-64","DOIUrl":null,"url":null,"abstract":"It has been held studying of the remote results of treatment of 80 patients sick of a bazalioma by 30 % glyciphon ointment in the Republican Oncologic Dispensary of the Ministry of Health of Republic of Tatarstan. It is established that daily use of glyciphon ointment during the 20– 30 days cures patients with primary tumours, both single, and initially-plural I and II stages, in 98,3 % cases. The preparation is effective at recidivations of bazalioma arising after radiotherapy, surgical treatment, criotherapy. The using at recidivations after the combined treatment is inexpedient. Reduction of an exposition of ointment from 24 hours till 6 hours gives good clinical effect with absence of relapses of recidivations of tumors.","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"6 1","pages":"60-64"},"PeriodicalIF":0.0000,"publicationDate":"2016-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Opuholi Golovy i Sei","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17650/2222-1468-2016-6-2-60-64","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

It has been held studying of the remote results of treatment of 80 patients sick of a bazalioma by 30 % glyciphon ointment in the Republican Oncologic Dispensary of the Ministry of Health of Republic of Tatarstan. It is established that daily use of glyciphon ointment during the 20– 30 days cures patients with primary tumours, both single, and initially-plural I and II stages, in 98,3 % cases. The preparation is effective at recidivations of bazalioma arising after radiotherapy, surgical treatment, criotherapy. The using at recidivations after the combined treatment is inexpedient. Reduction of an exposition of ointment from 24 hours till 6 hours gives good clinical effect with absence of relapses of recidivations of tumors.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
甘草软膏治疗基底细胞癌的临床体会
在鞑靼斯坦共和国卫生部共和国肿瘤诊所对80名bazalioma患者使用30% glyciphon软膏的远程治疗结果进行了研究。经证实,在20 - 30天内每天使用glyciphon软膏可治愈原发性肿瘤患者,包括单发和最初多发的I期和II期,在98.3%的病例中。该制剂对放射治疗、手术治疗、冷冻治疗后的巴扎瘤复发有效。联合治疗后再用是不合适的。将药膏暴露时间从24小时减少到6小时,临床效果良好,没有肿瘤复发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Opuholi Golovy i Sei
Opuholi Golovy i Sei Medicine-Otorhinolaryngology
CiteScore
0.40
自引率
0.00%
发文量
43
审稿时长
8 weeks
期刊最新文献
Current strategy of squamous cell carcinoma diagnosis and treatment Mutation profile of the tall cell variant of papillary thyroid carcinoma: analysis of 5 cases using wide-panel next-generation sequencing Results of implementation of a program of individual support of chemoradiation therapy in patients with head and neck tumors Value of 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in staging of patients with differentiated thyroid cancer after thyroidectomy during the first course of radioiodine therapy Microsurgical reconstruction of the hard palate after resections for malignant tumors
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1